- Home
- GILD vs TTE Comparison
GILD vs TTE Comparison
Compare GILD & TTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- TTE
- Stock Information
- Founded
- GILD 1987
- TTE 1924
- Country
- GILD United States
- TTE France
- Employees
- GILD N/A
- TTE N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- TTE Oil & Gas Production
- Sector
- GILD Health Care
- TTE Energy
- Exchange
- GILD Nasdaq
- TTE Nasdaq
- Market Cap
- GILD 119.7B
- TTE 138.8B
- IPO Year
- GILD 1992
- TTE 1991
- Fundamental
- Price
- GILD $109.95
- TTE $60.71
- Analyst Decision
- GILD Buy
- TTE Hold
- Analyst Count
- GILD 27
- TTE 5
- Target Price
- GILD $101.88
- TTE $72.42
- AVG Volume (30 Days)
- GILD 7.6M
- TTE 1.3M
- Earning Date
- GILD 02-11-2025
- TTE 02-05-2025
- Dividend Yield
- GILD 2.87%
- TTE 5.23%
- EPS Growth
- GILD N/A
- TTE N/A
- EPS
- GILD 0.38
- TTE 6.69
- Revenue
- GILD $28,754,000,000.00
- TTE $195,610,000,000.00
- Revenue This Year
- GILD $0.82
- TTE $12.97
- Revenue Next Year
- GILD $3.21
- TTE N/A
- P/E Ratio
- GILD $289.34
- TTE $8.78
- Revenue Growth
- GILD 6.04
- TTE N/A
- 52 Week Low
- GILD $62.07
- TTE $53.29
- 52 Week High
- GILD $111.03
- TTE $74.97
- Technical
- Relative Strength Index (RSI)
- GILD 75.82
- TTE 56.99
- Support Level
- GILD $94.56
- TTE $60.70
- Resistance Level
- GILD $106.69
- TTE $61.71
- Average True Range (ATR)
- GILD 2.29
- TTE 0.82
- MACD
- GILD 1.15
- TTE 0.02
- Stochastic Oscillator
- GILD 93.47
- TTE 69.23
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About TTE TotalEnergies SE
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2023, it produced 1.6 million barrels of liquids and 5.0 billion cubic feet of natural gas per day. At end-2023, reserves stood at 10.6 billion barrels of oil equivalent, 56% of which are liquids. During 2023, it had LNG sales of 44.3 metric tons. The company owns interests in refineries with capacity of nearly 2.0 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. At year-end, its gross installed renewable power generation capacity was 22.4 gigawatts.